Emel Yaman

565 total citations
41 papers, 419 citations indexed

About

Emel Yaman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Emel Yaman has authored 41 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in Emel Yaman's work include Cancer Treatment and Pharmacology (6 papers), Glioma Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Emel Yaman is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Glioma Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Emel Yaman collaborates with scholars based in Türkiye, United Kingdom and Germany. Emel Yaman's co-authors include Mustafa Beneklı, Süleyman Buyukberber, Banu Öztürk, Uğur Çoşkun, Ramazan Yıldız, Ali Kaya, Müge Akmansu, Banu Sancak, Aytuğ Üner and Özge Petek Erpolat and has published in prestigious journals such as International Immunopharmacology, Acta Neurochirurgica and Journal of Cancer Research and Clinical Oncology.

In The Last Decade

Emel Yaman

38 papers receiving 407 citations

Peers

Emel Yaman

ONCOL

PRM

GENET

Kathleen P. Lowler United States

Su-Mi Chung South Korea

Yukiko Komano Japan

Kerrie Clarke Australia

Dong Wu China

Elisabetta Froio Italy

Maria Grazia Viganò Italy

Sumito Sato Japan

Michela Maur Italy

Kathleen P. Lowler United States

Emel Yaman

227 ×1.4

ONCOL

73 ×0.6

PRM

114 ×1.0

88 ×1.0

GENET

27 ×0.5

Citations per year, relative to Emel Yaman Emel Yaman (= 1×) peers Kathleen P. Lowler

Countries citing papers authored by Emel Yaman

Since Specialization

Citations

This map shows the geographic impact of Emel Yaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emel Yaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emel Yaman more than expected).

Fields of papers citing papers by Emel Yaman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emel Yaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emel Yaman. The network helps show where Emel Yaman may publish in the future.

Co-authorship network of co-authors of Emel Yaman

This figure shows the co-authorship network connecting the top 25 collaborators of Emel Yaman. A scholar is included among the top collaborators of Emel Yaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emel Yaman. Emel Yaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erdem, Gökmen Umut, Mutlu Doğan, Abdullah Sakin, et al.. (2018). Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder. Oncology Research and Treatment. 41(4). 220–225. 2 indexed citations

Yaman, Emel, et al.. (2015). Malignant epitheloid angiomyolipoma of the kidney in a child treated with sunitinib, everolimus and axitinib. Canadian Urological Association Journal. 9(7-8). 542–542. 8 indexed citations

Yaman, Emel, et al.. (2013). Effects of cisplatin and panobinostat on human mesothelial (Met-5A) and malignant pleural mesothelioma (MSTO-211H) cells. Genetics and Molecular Research. 12(4). 5405–5413. 4 indexed citations

Kaya, Ali, Süleyman Buyukberber, Faysal Dane, et al.. (2010). Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer.. PubMed. 96(3). 400–4. 2 indexed citations

Yaman, Emel, Banu Öztürk, Uğur Çoşkun, et al.. (2010). Synchronous Bilateral Breast Cancer in an Aged Male Patient. Onkologie. 33(5). 255–258. 6 indexed citations

Yaman, Emel, Süleyman Buyukberber, Mustafa Beneklı, et al.. (2010). Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide. Clinical Neurology and Neurosurgery. 112(8). 662–667. 27 indexed citations

Kaya, Ali, Süleyman Buyukberber, Faysal Dane, et al.. (2010). Cisplatin plus Docetaxel Combination in the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer. Tumori Journal. 96(3). 400–404. 2 indexed citations

Yıldız, Ramazan, Mustafa Beneklı, Süleyman Buyukberber, et al.. (2010). The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer. Journal of Cancer Research and Clinical Oncology. 136(10). 1471–1476. 9 indexed citations

Kaya, Ali, et al.. (2009). Uterine Leiomyosarcoma Presenting with Neurological Symptoms: Differential Diagnosis. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(1). 281–284.

10.

Yıldız, Ramazan, Mustafa Beneklı, Nalân Akyürek, et al.. (2009). Non-Gestational Uterine Choriocarcinoma in a Postmenopausal Woman. Onkologie. 32(7). 8–8. 4 indexed citations

11.

Kaya, Ali, Süleyman Buyukberber, Mustafa Beneklı, et al.. (2009). Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer. Medical Oncology. 27(1). 152–157. 10 indexed citations

12.

Yaman, Emel, Uğur Çoşkun, Banu Öztürk, et al.. (2009). Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. Journal of Clinical Neuroscience. 16(4). 591–592. 13 indexed citations

13.

Öztürk, Banu, Uğur Çoşkun, Banu Sancak, et al.. (2009). Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors. International Immunopharmacology. 9(5). 645–648. 36 indexed citations

14.

Üner, Aytuğ, Banu Öztürk, Mustafa Beneklı, et al.. (2008). Synchronize Primary Breast Osteosarcoma and Contralateral Benign Cystosarcoma Phylloides: Radiologic and Pathologic Imaging. The Breast Journal. 14(1). 109–110. 5 indexed citations

15.

Kaya, Ali, Süleyman Buyukberber, Uğur Çoşkun, et al.. (2008). Acute erythema and edematous skin reaction and ectropion following docetaxel in a patient with non-small cell lung cancer. Cutaneous and Ocular Toxicology. 27(4). 327–331. 8 indexed citations

16.

Yaman, Emel, Banu Öztürk, Özlem Erdem, et al.. (2008). Histiocytic sarcoma: PET-CT evaluation of a rare entity. Annals of Nuclear Medicine. 22(8). 715–717. 19 indexed citations

17.

Yaman, Emel, Mustafa Beneklı, Uğur Çoşkun, et al.. (2008). Intrasellar plasmacytoma: an unusual presentation of multiple myeloma. Acta Neurochirurgica. 150(9). 921–924. 18 indexed citations

18.

Yaman, Emel, Süleyman Buyukberber, Aytuğ Üner, et al.. (2008). Temozolomide in Newly Diagnosed Malignant Gliomas: Administered Concomitantly with Radiotherapy, and Thereafter as Consolidation Treatment. Onkologie. 31(6). 309–313. 7 indexed citations

19.

Yaman, Emel, Uğur Çoşkun, Mustafa Beneklı, et al.. (2008). Coexistence of Gastrointestinal Stromal Tumor (GIST) of the Rectum and Adenocarcinoma of the Prostate in a Patient with Familial GIST. Oncology Research and Treatment. 31(12). 697–699. 7 indexed citations

20.

Öztürk, Banu, Süleyman Buyukberber, Uğur Çoşkun, et al.. (2007). Solitary iris metastasis from breast cancer with dramatic course: case report. Medical Oncology. 24(4). 463–465. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact